NURS 6501 ADVANCED PATHOPHYSIOLOGY WEEK 11 QUIZ
2026/2027 | 3 Sets with 125 Questions and Answers | Scored
100% | Pass Guaranteed - A+ Graded
QUIZ SET 1: Endocrine Pathophysiology (42 Questions)
Focusing on Diabetes Mellitus, Thyroid Disorders, and Adrenal/Pituitary
Pathophysiology
Diabetes Mellitus Pathophysiology – Type 1, Type 2, Gestational, and Acute
Complications
Q1: A 14-year-old patient presents with polyuria, polydipsia, weight loss of 15 pounds
over 3 weeks, and random glucose of 380 mg/dL. Which pathophysiologic mechanism
best explains this patient's condition?
A. Progressive insulin resistance in skeletal muscle with compensatory beta-cell
hyperfunction leading to relative insulin deficiency
B. Autoimmune destruction of pancreatic beta cells resulting in absolute insulin
deficiency and dependence on exogenous insulin [CORRECT]
C. Placental hormone-mediated insulin resistance causing transient glucose intolerance
during pregnancy
D. Chronic pancreatitis with fibrosis replacing exocrine and endocrine pancreatic tissue
Correct Answer: B
,Rationale: This presentation—acute onset in adolescence with classic triad of polyuria,
polydipsia, weight loss, and severe hyperglycemia—is pathognomonic for Type 1
diabetes mellitus. The underlying mechanism involves T-cell mediated autoimmune
destruction of pancreatic beta cells, typically associated with HLA-DR3, HLA-DR4
haplotypes and presence of islet cell antibodies (ICA), anti-GAD65, or anti-insulin
antibodies. This results in absolute insulin deficiency requiring lifelong insulin therapy.
Option A describes Type 2 diabetes pathophysiology, which has gradual onset in older
adults. Option C describes gestational diabetes. Option D describes pancreatogenic
diabetes.
Q2: In a patient with newly diagnosed Type 1 diabetes, which autoantibody is most
commonly detected and serves as a marker of ongoing beta-cell autoimmune
destruction?
A. Anti-insulin receptor antibodies causing insulin resistance in Type B syndrome
B. Islet cell antibodies (ICA) and anti-glutamic acid decarboxylase 65 (GAD65)
antibodies present in 70-80% of cases [CORRECT]
C. Anti-thyroid peroxidase antibodies associated with Hashimoto's thyroiditis
D. Anti-smooth muscle antibodies seen in autoimmune hepatitis
Correct Answer: B
Rationale: Islet cell antibodies (ICA) and GAD65 antibodies are the most prevalent
autoantibodies in Type 1 diabetes, found in 70-80% of patients at diagnosis, with ZnT8
and IA-2 antibodies also commonly present. These markers indicate ongoing
autoimmune destruction and can precede clinical onset by years. Anti-insulin receptor
antibodies (Option A) cause Type B insulin resistance syndrome, a rare form of severe
insulin resistance. Anti-TPO antibodies (Option C) and anti-smooth muscle antibodies
(Option D) are unrelated to diabetes pathophysiology.
Q3: A 58-year-old patient with Type 2 diabetes and metabolic syndrome presents with
blood glucose of 850 mg/dL, serum osmolality of 340 mOsm/kg, and altered mental
status. Arterial blood gas shows pH 7.35, bicarbonate 22 mEq/L. No ketones are
,detected in urine. What is the primary pathophysiologic distinction between this
condition and diabetic ketoacidosis?
A. Absolute insulin deficiency versus relative insulin deficiency as the primary defect
B. Presence of severe hyperosmolality with minimal ketosis versus ketosis and anion
gap metabolic acidosis [CORRECT]
C. Autoimmune etiology versus metabolic etiology of the underlying diabetes
D. Younger age of onset versus older age of onset with comorbidities
Correct Answer: B
Rationale: This patient has hyperglycemic hyperosmolar state (HHS), characterized by
severe hyperglycemia (>600 mg/dL), profound hyperosmolality (>320 mOsm/kg), and
altered mental status without significant ketosis or acidosis (pH typically >7.3,
bicarbonate >18 mEq/L). The key distinction from DKA is the absence of significant
ketosis and metabolic acidosis despite severe hyperglycemia. While HHS typically
occurs in Type 2 diabetes and DKA in Type 1, both can occur in either type depending on
precipitating factors such as infection or stress.
Q4: Which metabolic pathway is primarily responsible for ketone body production during
diabetic ketoacidosis?
A. Glycogenolysis in the liver breaking down stored glycogen to glucose
B. Lipolysis and beta-oxidation of fatty acids leading to ketogenesis in the liver with
accumulation of acetoacetate and beta-hydroxybutyrate [CORRECT]
C. Gluconeogenesis from amino acids in the renal cortex generating new glucose
D. Glycolysis in skeletal muscle converting glucose to pyruvate under anaerobic
conditions
Correct Answer: B
Rationale: In DKA, absolute insulin deficiency and elevated counter-regulatory hormones
(glucagon, cortisol, catecholamines, growth hormone) activate hormone-sensitive
lipase, causing uncontrolled lipolysis and release of free fatty acids. These undergo
beta-oxidation in hepatic mitochondria, producing excess acetyl-CoA that exceeds TCA
cycle capacity and is diverted to ketogenesis, producing acetoacetate,
beta-hydroxybutyrate, and acetone. This leads to anion gap metabolic acidosis.
, Glycogenolysis (Option A) and gluconeogenesis (Option C) contribute to hyperglycemia
but not ketosis. Glycolysis (Option D) is actually impaired in uncontrolled diabetes due
to lack of insulin-mediated glucose uptake.
Q5: A patient in DKA is receiving IV insulin therapy at 0.1 units/kg/hour. Which
electrolyte shift is most critical to monitor during the first 4-6 hours of treatment?
A. Dilutional hyponatremia as hyperglycemia corrects and water shifts extracellularly
B. Potassium shifts from extracellular to intracellular compartments causing
precipitous hypokalemia [CORRECT]
C. Hypercalcemia from bone resorption due to acidosis-induced calcium release
D. Hypomagnesemia from osmotic diuresis and urinary magnesium losses
Correct Answer: B
Rationale: Insulin administration activates Na+/K+-ATPase pumps, driving potassium
from extracellular fluid into cells. Despite initial presentation with hyperkalemia (due to
acidosis-driven intracellular H+/extracellular K+ exchange and insulin deficiency), total
body potassium is depleted from osmotic diuresis. Serum potassium can fall rapidly
with insulin therapy, potentially causing life-threatening cardiac arrhythmias. Current
guidelines recommend potassium replacement when serum K+ falls below 5.3 mEq/L if
urine output is adequate, with aggressive repletion for levels <3.3 mEq/L. While
hyponatremia (Option A) occurs, hypokalemia is more immediately dangerous.
Q6: Which adipokine is elevated in obesity and contributes to insulin resistance by
interfering with insulin receptor substrate phosphorylation and GLUT4 translocation?
A. Adiponectin which enhances insulin sensitivity and is decreased in obesity
B. Leptin which regulates appetite but does not directly impair insulin signaling
C. Tumor necrosis factor-alpha (TNF-α) and resistin which promote inflammation and
insulin resistance [CORRECT]
D. Ghrelin which stimulates appetite and is produced primarily in the stomach
Correct Answer: C
2026/2027 | 3 Sets with 125 Questions and Answers | Scored
100% | Pass Guaranteed - A+ Graded
QUIZ SET 1: Endocrine Pathophysiology (42 Questions)
Focusing on Diabetes Mellitus, Thyroid Disorders, and Adrenal/Pituitary
Pathophysiology
Diabetes Mellitus Pathophysiology – Type 1, Type 2, Gestational, and Acute
Complications
Q1: A 14-year-old patient presents with polyuria, polydipsia, weight loss of 15 pounds
over 3 weeks, and random glucose of 380 mg/dL. Which pathophysiologic mechanism
best explains this patient's condition?
A. Progressive insulin resistance in skeletal muscle with compensatory beta-cell
hyperfunction leading to relative insulin deficiency
B. Autoimmune destruction of pancreatic beta cells resulting in absolute insulin
deficiency and dependence on exogenous insulin [CORRECT]
C. Placental hormone-mediated insulin resistance causing transient glucose intolerance
during pregnancy
D. Chronic pancreatitis with fibrosis replacing exocrine and endocrine pancreatic tissue
Correct Answer: B
,Rationale: This presentation—acute onset in adolescence with classic triad of polyuria,
polydipsia, weight loss, and severe hyperglycemia—is pathognomonic for Type 1
diabetes mellitus. The underlying mechanism involves T-cell mediated autoimmune
destruction of pancreatic beta cells, typically associated with HLA-DR3, HLA-DR4
haplotypes and presence of islet cell antibodies (ICA), anti-GAD65, or anti-insulin
antibodies. This results in absolute insulin deficiency requiring lifelong insulin therapy.
Option A describes Type 2 diabetes pathophysiology, which has gradual onset in older
adults. Option C describes gestational diabetes. Option D describes pancreatogenic
diabetes.
Q2: In a patient with newly diagnosed Type 1 diabetes, which autoantibody is most
commonly detected and serves as a marker of ongoing beta-cell autoimmune
destruction?
A. Anti-insulin receptor antibodies causing insulin resistance in Type B syndrome
B. Islet cell antibodies (ICA) and anti-glutamic acid decarboxylase 65 (GAD65)
antibodies present in 70-80% of cases [CORRECT]
C. Anti-thyroid peroxidase antibodies associated with Hashimoto's thyroiditis
D. Anti-smooth muscle antibodies seen in autoimmune hepatitis
Correct Answer: B
Rationale: Islet cell antibodies (ICA) and GAD65 antibodies are the most prevalent
autoantibodies in Type 1 diabetes, found in 70-80% of patients at diagnosis, with ZnT8
and IA-2 antibodies also commonly present. These markers indicate ongoing
autoimmune destruction and can precede clinical onset by years. Anti-insulin receptor
antibodies (Option A) cause Type B insulin resistance syndrome, a rare form of severe
insulin resistance. Anti-TPO antibodies (Option C) and anti-smooth muscle antibodies
(Option D) are unrelated to diabetes pathophysiology.
Q3: A 58-year-old patient with Type 2 diabetes and metabolic syndrome presents with
blood glucose of 850 mg/dL, serum osmolality of 340 mOsm/kg, and altered mental
status. Arterial blood gas shows pH 7.35, bicarbonate 22 mEq/L. No ketones are
,detected in urine. What is the primary pathophysiologic distinction between this
condition and diabetic ketoacidosis?
A. Absolute insulin deficiency versus relative insulin deficiency as the primary defect
B. Presence of severe hyperosmolality with minimal ketosis versus ketosis and anion
gap metabolic acidosis [CORRECT]
C. Autoimmune etiology versus metabolic etiology of the underlying diabetes
D. Younger age of onset versus older age of onset with comorbidities
Correct Answer: B
Rationale: This patient has hyperglycemic hyperosmolar state (HHS), characterized by
severe hyperglycemia (>600 mg/dL), profound hyperosmolality (>320 mOsm/kg), and
altered mental status without significant ketosis or acidosis (pH typically >7.3,
bicarbonate >18 mEq/L). The key distinction from DKA is the absence of significant
ketosis and metabolic acidosis despite severe hyperglycemia. While HHS typically
occurs in Type 2 diabetes and DKA in Type 1, both can occur in either type depending on
precipitating factors such as infection or stress.
Q4: Which metabolic pathway is primarily responsible for ketone body production during
diabetic ketoacidosis?
A. Glycogenolysis in the liver breaking down stored glycogen to glucose
B. Lipolysis and beta-oxidation of fatty acids leading to ketogenesis in the liver with
accumulation of acetoacetate and beta-hydroxybutyrate [CORRECT]
C. Gluconeogenesis from amino acids in the renal cortex generating new glucose
D. Glycolysis in skeletal muscle converting glucose to pyruvate under anaerobic
conditions
Correct Answer: B
Rationale: In DKA, absolute insulin deficiency and elevated counter-regulatory hormones
(glucagon, cortisol, catecholamines, growth hormone) activate hormone-sensitive
lipase, causing uncontrolled lipolysis and release of free fatty acids. These undergo
beta-oxidation in hepatic mitochondria, producing excess acetyl-CoA that exceeds TCA
cycle capacity and is diverted to ketogenesis, producing acetoacetate,
beta-hydroxybutyrate, and acetone. This leads to anion gap metabolic acidosis.
, Glycogenolysis (Option A) and gluconeogenesis (Option C) contribute to hyperglycemia
but not ketosis. Glycolysis (Option D) is actually impaired in uncontrolled diabetes due
to lack of insulin-mediated glucose uptake.
Q5: A patient in DKA is receiving IV insulin therapy at 0.1 units/kg/hour. Which
electrolyte shift is most critical to monitor during the first 4-6 hours of treatment?
A. Dilutional hyponatremia as hyperglycemia corrects and water shifts extracellularly
B. Potassium shifts from extracellular to intracellular compartments causing
precipitous hypokalemia [CORRECT]
C. Hypercalcemia from bone resorption due to acidosis-induced calcium release
D. Hypomagnesemia from osmotic diuresis and urinary magnesium losses
Correct Answer: B
Rationale: Insulin administration activates Na+/K+-ATPase pumps, driving potassium
from extracellular fluid into cells. Despite initial presentation with hyperkalemia (due to
acidosis-driven intracellular H+/extracellular K+ exchange and insulin deficiency), total
body potassium is depleted from osmotic diuresis. Serum potassium can fall rapidly
with insulin therapy, potentially causing life-threatening cardiac arrhythmias. Current
guidelines recommend potassium replacement when serum K+ falls below 5.3 mEq/L if
urine output is adequate, with aggressive repletion for levels <3.3 mEq/L. While
hyponatremia (Option A) occurs, hypokalemia is more immediately dangerous.
Q6: Which adipokine is elevated in obesity and contributes to insulin resistance by
interfering with insulin receptor substrate phosphorylation and GLUT4 translocation?
A. Adiponectin which enhances insulin sensitivity and is decreased in obesity
B. Leptin which regulates appetite but does not directly impair insulin signaling
C. Tumor necrosis factor-alpha (TNF-α) and resistin which promote inflammation and
insulin resistance [CORRECT]
D. Ghrelin which stimulates appetite and is produced primarily in the stomach
Correct Answer: C
